Keyword Analysis & Research: ofatumumab

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
ofatumumab	0.89	0.6	5722	72	10

Keyword	CPC	PCC	Volume	Score
ofatumumab	1.14	1	9506	72
ofatumumab ms	1.99	0.4	5633	16
ofatumumab brand name	1.83	0.3	6839	33
ofatumumab kesimpta	0.63	0.4	8726	88
ofatumumab side effects	1.85	0.7	4359	33
ofatumumab novartis	0.39	0.8	9058	84
ofatumumab bnf	1.03	0.5	1369	100
ofatumumab mechanism of action	1.64	0.5	2595	24
ofatumumab spc	0.88	0.2	9736	63
ofatumumab rcm	0.71	0.8	2603	33
ofatumumab vs ocrelizumab	1.27	0.3	9854	27
ofatumumab vs rituximab	0.59	1	5151	69
ofatumumab package insert	2	0.7	3674	38
ofatumumab fda approval	0.03	0.8	3897	68
ofatumumab cost	0.04	0.8	8081	35
ofatumumab multiple sclerosis	1.31	0.1	790	22
ofatumumab fachinfo	1.6	0.6	5968	75

Ofatumumab: a novel monoclonal anti-CD20 antibody - PMC
microsoft.com

http://go.microsoft.com/fwlink/?LinkID=617350

WEBMay 10, 2010 · Ofatumumab, a novel humanized monoclonal anti-CD20 antibody, was recently approved by the FDA for the treatment of fludarabine and alemtuzumab refractory chronic lymphocytic leukemia (CLL).

DA: 31 PA: 58 MOZ Rank: 24